Acumen Pharmaceuticals (ABOS)
NASDAQ:ABOS
US Market
Holding ABOS?
Track your performance easily

Acumen Pharmaceuticals (ABOS) Financial Statements

403 Followers

Acumen Pharmaceuticals Financial Overview

Acumen Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.114; its P/E ratio is -2.84; Acumen Pharmaceuticals is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue--$ 5.00K-$ 4.00K
Gross Profit--$ 5.00K-$ 4.00K
EBIT$ -20.54M$ -13.87M$ -9.14M$ -16.04M$ -11.61M
EBITDA$ -18.73M$ -13.83M$ -9.10M$ -16.00M$ -11.22M
Net Income Common Stockholders$ -20.54M$ -14.87M$ -16.50M$ -12.96M$ -11.61M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 260.47M$ 252.51M$ 243.52M$ 215.43M$ 67.63M
Total Assets$ 288.91M$ 300.97M$ 310.13M$ 286.37M$ 177.41M
Total Debt$ 29.72M$ 30.58M$ 31.05M$ 2.00K$ 29.00K
Net Debt$ -230.75M$ -221.93M$ -212.47M$ -215.43M$ -67.60M
Total Liabilities$ 44.97M$ 38.93M$ 43.15M$ 6.10M$ 8.53M
Stockholders Equity$ 243.95M$ 262.00M$ 266.97M$ 280.27M$ 168.87M
Cash Flow-
Free Cash Flow$ -16.55M$ -17.87M$ -8.33M$ -12.91M$ -11.67M
Operating Cash Flow$ -16.55M$ -17.86M$ -8.31M$ -12.90M$ -11.67M
Investing Cash Flow$ 37.70M$ -9.20M$ -48.81M$ -92.00M$ 11.06M
Financing Cash Flow$ -128.00K$ 7.11M$ 29.13M$ 122.76M$ -145.00K
Currency in USD

Acumen Pharmaceuticals Earnings and Revenue History

Acumen Pharmaceuticals Debt to Assets

Acumen Pharmaceuticals Cash Flow

Acumen Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis